ICIs against programmed death-1 (PD-1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) proteins were highly effective in advanced dMMR metastatic colorectal cancer, especially combination therapy provided improved efficacy relative to anti-PD-1 monotherapy [45, 46]. Here, CTLA4 is linked to metastatic colorectal cancer.